Safety and Side Effects Common Side Effects and Management GLP-1 receptor agonists are generally well-received, but they can lead to some predictable gastrointestinal issues in women with PCOS
NEWSLETTER Signup & Smile Subscribe to receive updates, access to exclusive deals, and more.
Sometimes, small changes in your daily habits end up helping more than changing the dose
Although no data from head-to-head trials comparing retatrutide to other currently approved obesity treatments exist, data from the phase 2 studies with retatrutide suggest that at higher doses, retatrutide could lead to greater WL compared to the most efficacious approved treatments for obesity and T2D such as tirzepatide 15 mg and semaglutide 2.4 mg (Fig
Our CoolSculpting experts will assess your unique body goals and create a personalized treatment plan that targets your specific areas of concern
Since tesamorelin increases IGF-1, patients with diabetes who are receiving ongoing treatment with tesamorelin should be monitored at regular intervals for potential development or worsening of retinopathy